Cargando…
Expansion of Bone Precursors through Jun as a Novel Treatment for Osteoporosis-Associated Fractures
Osteoporosis and osteoporotic fractures lead to decreased life quality and high healthcare costs. Current treatments prevent losses in bone mass and fractures to some extent but have side effects. Therefore, better therapies are needed. This study investigated whether the transcription factor Jun ha...
Autores principales: | Lerbs, Tristan, Cui, Lu, Muscat, Claire, Saleem, Atif, van Neste, Camille, Domizi, Pablo, Chan, Charles, Wernig, Gerlinde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160304/ https://www.ncbi.nlm.nih.gov/pubmed/32197115 http://dx.doi.org/10.1016/j.stemcr.2020.02.009 |
Ejemplares similares
-
Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity
por: Cui, Lu, et al.
Publicado: (2020) -
CD47 prevents the elimination of diseased fibroblasts in scleroderma
por: Lerbs, Tristan, et al.
Publicado: (2020) -
Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors
por: Cui, Lu, et al.
Publicado: (2021) -
Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations
por: Borrelli, Mimi R., et al.
Publicado: (2020) -
Innate immune cell activation causes lung fibrosis in a humanized model of long COVID
por: Cui, Lu, et al.
Publicado: (2023)